Alteração da complacência intracraniana em paciente com doença renal crônica e diabetes mellitus T1: um relato de caso
Keywords:Intracranial hypertension; Diabetic nephropathies; Furosemide; Hydrochlorothiazide.
Objective: The aim of this study was to relate the clinical profile with data on blood pressure (BP), intracranial pressure (ICP) and laboratory tests of a patient with Diabetes mellitus (DM) type 1 and chronic kidney disease (CKD) stage 5. Methodology: The research was carried out at the renal replacement therapy outpatient clinic of the Santa Casa de Misericórdia hospital, in Ponta Grossa-PR, previously approved by the ethics committee, under opinion nº 4,039,453. ICP monitoring and BP measurement were performed twice, on follow-up consultation days, in February and September 2020. In addition to the aforementioned parameters, a questionnaire on the patient's habits and demographic data was applied, and a consultation was carried out with the patient medical record for the collection of laboratory test data. Results: From February to September, the volunteer presented with persistent Systemic Arterial Hypertension (SAH) and hyperglycemia, and worsening of laboratory parameters. In February, the ICP morphology showed a significant change, suggesting intracranial hypertension, and the patient had a great impairment of visual acuity. In September, despite the worsening of the health condition, there was a significant improvement in vision and, also, an improvement in the ICP parameters, approaching normality. Between consultations, the diuretic administered by the patient was replaced. Conclusion: it is suggested that the visual impairment is due to intracranial hypertension and the improvement of both is related to the replacement of hydrochlorothiazide by furosemide, which occurred between consultations.
Aboelela, M. A. & Alrefaey, A. K. (2020). Brain-Relaxing Effect of Different Diuretic Regimens in Supratentorial Tumor Surgery: A Comparative Study Guided by Optic Nerve Sheath Diameter. Anesthesia, essays and researches, 14(3), 531–535. https://doi.org/10.4103/aer.AER_15_21
Aghadavoud E., Nasri H. & Amiri M. (2017). Molecular signaling pathways of diabetic kidney disease; new concepts. J Prev Epidemiol, 2 (2), e09.
Armstead W. M. (2016). Cerebral Blood Flow Autoregulation and Dysautoregulation. Anesthesiology clinics, 34(3), 465–477. https://doi.org/10.1016/j.anclin.2016.04.002
Ballestero, M., Frigieri, G., Cabella, B., de Oliveira, S. M. & de Oliveira, R. S. (2017). Prediction of intracranial hypertension through noninvasive intracranial pressure waveform analysis in pediatric hydrocephalus. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery, 33(9), 1517–1524. https://doi.org/10.1007/s00381-017-3475-1
Carlsson S. (2019). Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes. Frontiers in physiology, 10, 320. https://doi.org/10.3389/fphys.2019.00320
Curone, M., Peccarisi, C., & Bussone, G. (2015). Headache attributed to intracranial pressure alterations: applicability of the International Classification of Headache Disorders ICHD-3 beta version versus ICHD-2. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 36 Suppl 1, 137–139. https://doi.org/10.1007/s10072-015-2202-5
Dussol, B. et al. (2005). A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 20(2), 349–353. https://doi.org/10.1093/ndt/gfh650
Friedman D. I. (2019). Headaches in Idiopathic Intracranial Hypertension. Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society, 39(1), 82–93. https://doi.org/10.1097/WNO.0000000000000777
Hayreh S. S. (2016). Pathogenesis of optic disc edema in raised intracranial pressure. Progress in retinal and eye research, 50, 108–144. https://doi.org/10.1016/j.preteyeres.2015.10.001
Kawasoe, S. et al. (2017). Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes. BMC pharmacology & toxicology, 18(1), 23. https://doi.org/10.1186/s40360-017-0125-x
Mascarenhas, S. et al. (2012). The new ICP minimally invasive method shows that the Monro-Kellie doctrine is not valid. Acta neurochirurgica. Supplement, 114, 117–120. https://doi.org/10.1007/978-3-7091-0956-4_21
Ohishi M. (2018). Hypertension with diabetes mellitus: physiology and pathology. Hypertension research: official journal of the Japanese Society of Hypertension, 41(6), 389–393. https://doi.org/10.1038/s41440-018-0034-4
Onodera, H., Oshio, K., Uchida, M., Tanaka, Y., & Hashimoto, T. (2012). Analysis of intracranial pressure pulse waveform and brain capillary morphology in type 2 diabetes mellitus rats. Brain research, 1460, 73–77. https://doi.org/10.1016/j.brainres.2012.03.061
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [e book]. Santa Maria. Ed. UAB/NTE/UFSM. Recuperado de <https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_MetodologiaPesquisa-Cientifica.pdf?sequence=1>.
Rickli, C. et al. (2021). Use of non-invasive intracranial pressure pulse waveform to monitor patients with End-Stage Renal Disease (ESRD). PloS one, 16(7), e0240570. https://doi.org/10.1371/journal.pone.0240570
Sagoo, M. K., & Gnudi, L. (2018). Diabetic nephropathy: Is there a role for oxidative stress?. Free radical biology & medicine, 116, 50–63. https://doi.org/10.1016/j.freeradbiomed.2017.12.040
Selby, N. M., & Taal, M. W. (2020). An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes, obesity & metabolism, 22 Suppl 1, 3–15. https://doi.org/10.1111/dom.14007
Seravalle, G. & Grassi, G. (2016). Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome. High blood pressure & cardiovascular prevention: the official journal of the Italian Society of Hypertension, 23(3), 175–179. https://doi.org/10.1007/s40292-016-0137-4
Shibata, S., Ishizawa, K. & Uchida, S. (2017). Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension. Hypertension research: official journal of the Japanese Society of Hypertension, 40(3), 221–225. https://doi.org/10.1038/hr.2016.137
Stefanits, H.; Reinprecht, A.; Klein, K. U.; Mashour, G. A. & Engelhard, K. (2019) Intracranial Pressure. In: Oxford Textbook of Neuroscience and Anaesthesiology. United Kingdom: Oxford University Press.
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017). Chronic Kidney Disease. Lancet (London, England), 389(10075), 1238–1252. https://doi.org/10.1016/S0140-6736(16)32064-5
How to Cite
Copyright (c) 2022 Mariana Schechtel Koch; Bianca Drewnowski; Edimara Rafaelli Balzer; Gilberto Baroni; Adriana Fatima Menegat Schuinski ; José Carlos Rebuglio Vellosa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.